Report / Paper metadata
BIOCARD framework: integrating fecal bile acids, lipids, and metabolites to assess response to a cardiovascular health intervention.
BIOCARD examines faecal molecular changes after a garden-based health programme. The exploratory analysis found differences that conventional indicators did not readily detect, but a molecular difference is not proof of lower cardiovascular disease risk.
What evidence was collected?
Caregiver-child participants came from a ten-week randomised trial comparing a multicomponent garden-based intervention with an education-only group. Researchers analysed faecal bile acids, lipids and other metabolites, combining these measurements with conventional health indicators. The framework is an exploratory analysis method, not a validated diagnostic test.
What did the analysis find?
The report describes intervention-associated molecular differences, with more apparent variation in children than in parents. Network analysis connected selected molecular features with indicators such as blood pressure, body fat and diet-quality scores. These are observed associations within the analysed data.
Why are molecular signals not clinical outcomes?
A difference in faecal metabolites may help researchers form hypotheses about biological responses. It does not by itself show fewer heart attacks, less disease progression or a durable improvement in health. The abstract does not report those outcomes or validate the molecular features as substitutes for them.
What would strengthen the evidence?
The full study would need to show sample sizes, effect estimates, uncertainty, handling of many comparisons and performance in a separate group before a predictive claim could be judged. Mechanistic associations also need evidence beyond a network diagram to show causation. This explanation is based on the abstract and does not present BIOCARD as ready for clinical use.
- Journal
- Gut microbes
- Kind
- Paper metadata
- Identifier
- PMID 42627058